Full-Time

Development Systems Analyst

Confirmed live in the last 24 hours

Unlearn AI

Unlearn AI

51-200 employees

Creates AI-driven digital twins for healthcare

AI & Machine Learning
Healthcare

Compensation Overview

$97kAnnually

Junior

San Francisco, CA, USA

Full-time position based in San Francisco.

Category
DevOps & Infrastructure
DevOps Engineering
Required Skills
Development Operations (DevOps)
Requirements
  • Bachelors in Computer Science
  • 24 months as DevOps/Systems Professional
  • Experience working w/JFrog, Artifactory, GitLab & SonarQube
Responsibilities
  • Work with and lead engineers on the design, deployment and continuous improvement of important infrastructure services;
  • Provide input into long-range platform requirements and operational guidelines, with a focus on automation and continuous improvement;
  • Develop and maintain system-level automated testing suites.

Unlearn.AI creates digital twins of patients using artificial intelligence, which are virtual replicas that simulate potential health outcomes. This technology allows healthcare providers to predict how a patient's health may change over time, leading to more informed treatment decisions. The primary clients include healthcare providers and pharmaceutical companies, who can use these digital twins in clinical trials to replace traditional control groups, potentially speeding up drug development and approval processes. Unlearn.AI differentiates itself by focusing on AI-driven simulations that reduce the need for actual human control groups, which can save time and resources. The company's goal is to enhance decision-making in patient care and drug development through advanced predictive modeling.

Company Stage

Series C

Total Funding

$127.1M

Headquarters

San Francisco, California

Founded

2017

Growth & Insights
Headcount

6 month growth

0%

1 year growth

10%

2 year growth

39%
Simplify Jobs

Simplify's Take

What believers are saying

  • The recent $50 million Series C funding round positions Unlearn.AI for aggressive expansion and accelerated product development.
  • The appointment of Steve Herne as Chief Commercial Officer brings extensive experience in healthcare innovation, likely propelling the company's commercial strategies.
  • Unlearn.AI's innovative tools like TrialPioneer and TwinRCT 3.0 can make clinical trial planning more efficient, offering significant advantages over traditional methods.

What critics are saying

  • The high-stakes nature of AI and biotech innovations means that Unlearn.AI could face significant legal challenges, particularly around trade secrets and intellectual property.
  • The rapidly evolving digital health market requires continuous innovation, which could strain Unlearn.AI's resources and capabilities.

What makes Unlearn AI unique

  • Unlearn.AI's use of digital twins to simulate patient health outcomes is a unique approach in the healthcare technology sector, setting it apart from traditional clinical trial methods.
  • The company's focus on AI-driven simulations for clinical trials can significantly reduce the need for human control groups, speeding up drug development and approval processes.
  • Unlearn.AI's TwinRCT solution, which enhances decision-making in Phase II trials, provides a robust framework that is not commonly found in other AI-based clinical trial solutions.

Help us improve and share your feedback! Did you find this helpful?